Autophagy and Cancer Therapy

被引:243
作者
Thorburn, Andrew [1 ]
Thamm, Douglas H. [2 ]
Gustafson, Daniel L. [2 ]
机构
[1] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA
[2] Colorado State Univ, Flint Anim Canc Ctr, Dept Clin Sci, Ft Collins, CO 80523 USA
基金
美国国家卫生研究院;
关键词
HISTONE DEACETYLASE INHIBITORS; CHEMOTHERAPY-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM STRESS; INDUCED CELL-DEATH; TARGETING AUTOPHAGY; COLON-CANCER; INDUCED CYTOTOXICITY; MYELOMA CELLS; HMGB1; RELEASE; TUMOR-CELLS;
D O I
10.1124/mol.114.091850
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Autophagy is the process by which cellular material is delivered to lysosomes for degradation and recycling. There are three different types of autophagy, but macroautophagy, which involves the formation of double membrane vesicles that engulf proteins and organelles that fuse with lysosomes, is by far the most studied and is thought to have important context-dependent roles in cancer development, progression, and treatment. The roles of autophagy in cancer treatment are complicated by two important discoveries over the past few years. First, most (perhaps all) anticancer drugs, as well as ionizing radiation, affect autophagy. In most, but not all cases, these treatments increase autophagy in tumor cells. Second, autophagy affects the ability of tumor cells to die after drug treatment, but the effect of autophagy may be to promote or inhibit cell death, depending on context. Here we discuss recent research related to autophagy and cancer therapy with a focus on how these processes may be manipulated to improve cancer therapy.
引用
收藏
页码:830 / 838
页数:9
相关论文
共 105 条
  • [1] Autophagy delays apoptotic death in breast cancer cells following DNA damage
    Abedin, M. J.
    Wang, D.
    McDonnell, M. A.
    Lehmann, U.
    Kelekar, A.
    [J]. CELL DEATH AND DIFFERENTIATION, 2007, 14 (03) : 500 - 510
  • [2] Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
    Amaravadi, Ravi K.
    Yu, Duonan
    Lum, Julian J.
    Bui, Thi
    Christophorou, Maria A.
    Evan, Gerard I.
    Thomas-Tikhonenko, Andrei
    Thompson, Craig B.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (02) : 326 - 336
  • [3] Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
    Amaravadi, Ravi K.
    Lippincott-Schwartz, Jennifer
    Yin, Xiao-Ming
    Weiss, William A.
    Takebe, Naoko
    Timmer, William
    DiPaola, Robert S.
    Lotze, Michael T.
    White, Eileen
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (04) : 654 - 666
  • [4] Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling
    Bareford, M. Danielle
    Hamed, Hossein A.
    Allegood, Jeremy
    Cruickshanks, Nichola
    Poklepovic, Andrew
    Park, Margaret A.
    Ogretmen, Besim
    Spiegel, Sarah
    Grant, Steven
    Dent, Paul
    [J]. CANCER BIOLOGY & THERAPY, 2012, 13 (09) : 793 - 803
  • [5] Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells
    Bareford, M. Danielle
    Park, Margaret A.
    Yacoub, Adly
    Hamed, Hossein A.
    Tang, Yong
    Cruickshanks, Nichola
    Eulitt, Patrick
    Hubbard, Nisan
    Tye, Gary
    Burow, Matthew E.
    Fisher, Paul B.
    Moran, Richard G.
    Nephew, Kenneth P.
    Grant, Steven
    Dent, Paul
    [J]. CANCER RESEARCH, 2011, 71 (14) : 4955 - 4967
  • [6] Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
    Bellodi, Cristian
    Lidonnici, Maria Rosa
    Hamilton, Ashley
    Helgason, G. Vignir
    Soliera, Angela Rachele
    Ronchetti, Mattia
    Galavotti, Sara
    Young, Kenneth W.
    Selmi, Tommaso
    Yacobi, Rinat
    Van Etten, Richard A.
    Donato, Nick
    Hunter, Ann
    Dinsdale, David
    Tirro, Elena
    Vigneri, Paolo
    Nicotera, Pierluigi
    Dyer, Martin J.
    Holyoake, Tessa
    Salomoni, Paolo
    Calabretta, Bruno
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (05) : 1109 - 1123
  • [7] The LIR motif - crucial for selective autophagy
    Birgisdottir, Asa Birna
    Lamark, Trond
    Johansen, Terje
    [J]. JOURNAL OF CELL SCIENCE, 2013, 126 (15) : 3237 - 3247
  • [8] MONITORING AUTOPHAGIC DEGRADATION OF P62/SQSTM1
    Bjorkoy, Geir
    Lamark, Trond
    Pankiv, Serhiy
    Overvatn, Aud
    Brech, Andreas
    Johansen, Terje
    [J]. METHODS IN ENZYMOLOGY: AUTOPHAGY IN MAMMALIAN SYSTEMS, VOL 452, PT B, 2009, 452 : 181 - 197
  • [9] Autophagy Inhibition for Chemosensitization and Radiosensitization in Cancer: Do the Preclinical Data Support This Therapeutic Strategy?
    Bristol, Molly L.
    Emery, Sean M.
    Maycotte, Paola
    Thorburn, Andrew
    Chakradeo, Shweta
    Gewirtz, David A.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 344 (03) : 544 - 552
  • [10] Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: The role of autophagy
    Bursch, W
    Ellinger, A
    Kienzl, H
    Torok, L
    Pandey, S
    Sikorska, M
    Walker, R
    Hermann, RS
    [J]. CARCINOGENESIS, 1996, 17 (08) : 1595 - 1607